Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $577 | $214 | $216 | $45 |
| Short-Term Investments | $0 | $0 | $0 | $42 |
| Receivables | $78 | $0 | $0 | $7 |
| Inventory | $0 | $0 | $0 | -$42 |
| Other Curr. Assets | $44 | $42 | $62 | $66 |
| Total Curr. Assets | $699 | $256 | $278 | $118 |
| Property Plant & Equip (Net) | $4 | $19 | $51 | $89 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,651 | $2,658 | $3,664 | $4,036 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $903 | $11 |
| Other NC Assets | $0 | $0 | -$903 | -$11 |
| Total NC Assets | $1,655 | $2,676 | $3,715 | $4,124 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,354 | $2,932 | $3,993 | $4,243 |
| Liabilities | – | – | – | – |
| Payables | $178 | $19 | $3 | $19 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $178 | $19 | $3 | $19 |
| LT Debt | $3,744 | $3,744 | $2,246 | $0 |
| Deferred Rev, NC | $0 | $0 | $903 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | -$903 | $987 |
| Other NC Liab. | $0 | $3,570 | $3,570 | $3,570 |
| Total NC Liab. | $3,744 | $7,313 | $5,815 | $4,557 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,922 | $7,332 | $5,819 | $4,576 |
| Equity | – | – | – | – |
| Pref Stock | $1,835 | $1,522 | $1,236 | $951 |
| Common Stock | $7 | $6 | $6 | $6 |
| Retained Earnings | -$19,812 | -$17,877 | -$15,084 | -$13,372 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $16,402 | $11,950 | $12,016 | $12,081 |
| Total Equity | -$1,568 | -$4,400 | -$1,826 | -$334 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,354 | $2,932 | $3,993 | $4,243 |
| Net Debt | $3,167 | $3,530 | $2,030 | -$45 |